Genomic & Biopharma News

Maternal age at transition to motherhood predicts risky drinking behavior
People tend to adjust behaviors across their lifespans as they adopt new roles – such as marriage or parenting – that are incompatible with prior behaviors.
News Medical Life Sciences, 2017-08-24 07:54:02

Accelerated Pharma puts the brakes on IPO
After nearly a year and three term revisions, Accelerated Pharma is pulling its initial public offering.
Fierce Biotech, 2017-08-24 07:51:02

High level of heart disease pipeline innovation could bridge unmet need in treating CVD
With over 1,400 products in active development, the innovation pipeline for cardiovascular disease (CVD) is extensive, with four key CVD indications – hypertension, heart failure, dyslipidemia and thrombosis – now accounting for around half of all pipeline innovation, according to GBI Research, a recognized leader in providing business information and analytics.
News Medical Life Sciences, 2017-08-24 07:44:25

FDA, EMA and EC sign new confidentiality commitment
The US Food and Drug Administration can now share non-public and commercially confidential information, including trade secrets relating to medicines inspections, with EU regulators after the parties signed a new commitment.
PharmaTimes, 2017-08-24 07:42:39

Researchers repurpose diabetes drug for brain pressure
Research led by the University of Birmingham indicates that a GLP-1 agonist drug, currently used to lower blood sugar in people with type II diabetes, could be repurposed to treat raised brain pressure.
PharmaTimes, 2017-08-24 07:35:27

Merck sees promise in Macrophage Pharma
Merck Ventures has become the latest group to invest in Macrophage Pharma and take a position on the UK biotech’s board of directors.
PharmaTimes, 2017-08-24 07:19:30

Extended use of AZ’ Brilinta cuts CV death risk 29%
Long-term use of AstraZeneca’s Brilinta in patients with a history of heart attack reduces the risk of cardiovascular death by 29 percent, a new sub analysis of data from the Phase III PEGASUS-TIMI 54 trial has found.
PharmaTimes, 2017-08-24 07:12:35

Novartis breast cancer drug Kisqali wins EU approval
Novartis has announced the launch of its new breast cancer drug Kisqali in the UK today following a green light from European regulators.
PharmaTimes, 2017-08-24 07:07:13

Consumption of EPA and DHA omega-3s reduces cardiac death risk, study shows
Results from a new study published in the Journal of Clinical Lipidology showed that in 14 randomized, controlled trials of 71,899 people, consumption of EPA and DHA omega-3s reduced the risk of cardiac death by a statistically-significant average of 8 percent.
News Medical Life Sciences, 2017-08-24 07:00:44